百利天恒股价涨5.02%，东方阿尔法基金旗下1只基金重仓，持有2.64万股浮盈赚取50.87万元

Group 1 - The core viewpoint of the news is the performance and financial status of Sichuan Baili Tianheng Pharmaceutical Co., Ltd., which saw a stock price increase of 5.02% to 403.26 CNY per share, with a total market capitalization of 161.707 billion CNY [1] - The company was established on August 17, 2006, and went public on January 6, 2023, focusing on the research, production, and sales of pharmaceuticals [1] - The main business revenue composition indicates that 99.57% is recognized at a specific point in time, while 0.43% is recognized over a specific period [1] Group 2 - From the perspective of fund holdings, the Oriental Alpha Fund has a significant position in Baili Tianheng, with the Oriental Alpha Healthcare Mixed Fund A (014841) reducing its holdings by 32,900 shares, now holding 26,400 shares, which represents 4.92% of the fund's net value [2] - The fund has achieved a year-to-date return of 61.16%, ranking 334 out of 8,179 in its category, and a one-year return of 68.02%, ranking 1,385 out of 7,984 [2] - The fund manager, Meng Yu, has been in position for 1 year and 286 days, with the fund's total assets amounting to 169 million CNY, achieving a best return of 40.45% and a worst return of 15.84% during his tenure [3]